SOURCE: Burrill & Company

May 16, 2011 07:00 ET

Meet Top Biotech Executives at The Burrill Latin America Life Sciences Conference, May 19-20 in Rio

SAN FRANCISCO, CA--(Marketwire - May 16, 2011) - Executives from Monsanto, Sanofi, and BNDES will join former Pfizer CEO Jeff Kindler at The Burrill Latin America Life Sciences Conference, May 19-20, in Rio de Janeiro, Brazil. This intimate conference offers attendees a unique opportunity to meet with industry leaders in Latin America.

Gain insight into the business opportunities and regional advances making Latin America a new center for innovation, research, and development of biopharmaceuticals and biofuels. The two-day event, features speakers and panelists such as:

  • Burrill & Company, G. Steven Burrill, CEO
  • Pfizer, Jeff Kindler, Former CEO
  • Sanofi, Dr. Jaderson Lima, Medical and Scientific Alliances Director
  • Monsanto, Vicky Gavrias, Director of Biotechnology
  • University of California-Irvine, Dr. Hans Keirstead, Professor
  • BNDES, Sérgio Weguelin, Executive Director, Amazon Fund
  • BNDES, Pedro Palmeira, Executive Director, PROFARMA
  • EMBRAPA, Dr. Raul Rosinha, Director, Technology Transfer and Business

Topics that will be covered include:

  • Intellectual property and patents: A regional perspective
  • Government and private initiatives to foster the industry of innovation
  • Biofuels and sustainable agriculture
  • Case studies and successful strategies to advance life sciences R&D in Latin America

The conference brings together corporate executives, financiers, regulators, government officials and academic leaders from around the world to discuss the current state of life sciences with industry leaders in Latin America. To register for this event and for additional information, visit

About Burrill & Company
Founded in 1994, Burrill & Company is a diversified global financial services firm focused on the life sciences industry. With more than $1 billion in assets under management, the firm's businesses include venture capital, private equity, merchant banking and media. By leveraging the scientific and business networks of its investment team, Burrill & Company has established unrivaled access and visibility in the life sciences industry. This unique combination of resources and capabilities enables the company to provide life sciences companies with capital, management expertise, insight, market intelligence and analysis through its investments, conferences, and publications. Headquartered in San Francisco, the company oversees a global network of offices throughout the United States, Latin America, Europe and Asia. For more information visit:

Contact Information